.avif)
San Diego, August 14, 2019 – Inc. magazine today revealed that Scientist.com, the world’s largest enterprise marketplace for outsourced R&D services, ranked no. 289 on its Inc. 5000 list, the prestigious ranking of the nation’s fastest-growing private companies. The annual ranking, now in its 38th year, represents a unique look at the most successful companies within the American economy. Microsoft, Dell, Pandora, LinkedIn, Yelp, Zillow and many other well-known names gained their first national exposure as honorees on the Inc. 5000.
“Our mission at Scientist.com is to empower and connect scientists worldwide - and make it possible to cure all human diseases by 2050,” stated Kevin Lustig, PhD, Scientist.com’s CEO and Founder. “We are succeeding because of the hard work, talent and dedication of our incredible employees.”
Founded out of Lustig’s home in 2007, Scientist.com is the pharmaceutical industry’s leading enterprise gateway marketplace. By connecting research scientists and facilitating the creation and purchase of complex services and products, Scientist.com enables pharma and biotech companies to save time, reduce costs and promote innovation, while also ensuring that all transactions are compliant with internal regulations. With such a strong value proposition, Scientist.com has the potential to solve the major challenge facing the pharmaceutical industry – how to create more drugs for less money and in less time.
“The companies on this year’s Inc. 5000 have followed so many different paths to success,” says Inc. editor in chief James Ledbetter. “There’s no single course you can follow or investment you can take that will guarantee this kind of spectacular growth. But what they have in common is persistence and seizing opportunities.”
Complete results of the Inc. 5000, including company profiles and an interactive database can be found at www.inc.com/inc5000. Scientist.com and other top-500 companies are featured in the September issue of Inc.
.webp)
Scientist.com
Scientist.comは、科学研究のアウトソーシングという複雑な業務のために構築された、世界最大かつ初のプラットフォームです。
私たちは、製薬・バイオテクノロジー企業が、創薬や前臨床研究から臨床開発、製造、メディカルアフェアーズ、そして商業化に至るまで、パイプラインのあらゆる段階を支えるプロバイダーとの関係を構築、管理、拡大できるよう支援しています。一元化されたプラットフォームを通じて、組織は6,000社以上のグローバルなプロバイダーネットワークにアクセスし、調達ワークフローの効率化、コンプライアンスの維持、サプライヤー関係の管理を実現するとともに、データに基づいた洞察を活用して、より迅速かつ的確な意思決定を行うことが可能です。
現在、Scientist.comは世界の製薬企業トップ30社のうち24社を含む130以上のライフサイエンス関連組織を支援しており、業務の複雑さを軽減し、開発期間を短縮し、イノベーションをより迅速に患者へ届けるためのサポートを行っています。私たちの使命は、2050年までに人類のあらゆる疾患を治癒可能にすることです。